|
AIMP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.52850000001425E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.34180000000018E-05 |
| Normal-vs-Stage2 |
8.996200E-04 |
| Normal-vs-Stage3 |
3.39910000035637E-07 |
| Normal-vs-Stage4 |
2.2593000026383E-08 |
| Stage1-vs-Stage2 |
6.972000E-01 |
| Stage1-vs-Stage3 |
7.526200E-02 |
| Stage1-vs-Stage4 |
1.297620E-02 |
| Stage2-vs-Stage3 |
4.081000E-01 |
| Stage2-vs-Stage4 |
2.259400E-01 |
| Stage3-vs-Stage4 |
5.580000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.579099999649E-07 |
| Normal-vs-AfricanAmerican |
1.041700E-02 |
| Normal-vs-Asian |
1.458750E-03 |
| Caucasian-vs-AfricanAmerican |
4.584400E-01 |
| Caucasian-vs-Asian |
3.208400E-01 |
| AfricanAmerican-vs-Asian |
9.982600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.01860000004217E-06 |
| Normal-vs-Female |
1.51188999999441E-05 |
| Male-vs-Female |
5.608400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.634700E-04 |
| Normal-vs-Age(41-60Yrs) |
3.27609999994927E-06 |
| Normal-vs-Age(61-80Yrs) |
2.50589999861717E-08 |
| Normal-vs-Age(81-100Yrs) |
2.435600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.536190E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.199500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.218800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.228800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.154200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.994600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.779820E-02 |
| Classical-VS-Follicular |
6.006000E-01 |
| Classical-VS-Other |
6.849200E-01 |
| Classical-VS-Normal |
2.06600000000057E-05 |
| Tall-VS-Follicular |
1.669960E-01 |
| Tall-VS-Other |
6.771600E-01 |
| Tall-VS-Normal |
1.55759999997951E-06 |
| Follicular-VS-Other |
8.929400E-01 |
| Follicular-VS-Normal |
3.016100E-04 |
| Other-VS-Normal |
4.366300E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.06519999998334E-06 |
| Normal-vs-N1 |
1.70139999999819E-06 |
| N0-vs-N1 |
3.239800E-01 |
|
|
